Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,4 Dihydroxynorephedrine
2. 3,4-dihydroxynorephedrine
3. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol
4. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol Hydrochloride, (r*,r*)-(+,-)-isomer
5. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol Hydrochloride, (r*,s*)-(+-)-isomer
6. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol Tartrate, (r*,r*), (r*,r*)-isomer
7. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol Tartrate, (r*,s*), (r*,r*)-isomer
8. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol, (r*,r*)-isomer
9. 4-(2-amino-1-hydroxypropyl)-1,2-benzenediol, (r*,s*)-isomer
10. Alpha Methylnoradrenaline
11. Alpha Methylnorepinephrine
12. Alpha-methylnoradrenaline
13. Alpha-methylnorepinephrine
14. Cobefrine
15. Corbadrine
16. Hydrochloride, Nordefrin
17. Levonordefrin
18. Methylnorepinephrine
19. Neo Cobefrin
20. Neo-cobefrin
21. Neocobefrin
22. Nordefrin
23. Nordefrin Hydrochloride
24. Nordefrin Hydrochloride, (r*,r*)-(+,-)-isomer
25. Nordefrin Hydrochloride, (r*,s*)-(+,-)-isomer
26. Nordefrin Tartrate, (r*,r*), (r*,r*) Isomer
27. Nordefrin Tartrate, (r*,s*), (r*,r*) Isomer
28. Nordefrin, (r*,r*)-isomer
29. Nordefrin, (r*,s*)-isomer
30. Norephrine
1. Levonordefrin Hcl
2. 10390-18-8
3. Corbadrine Hydrochloride
4. L-nordefrin Hydrochloride
5. Nordefrin Hcl
6. Dl-corbadrine Hydrochloride
7. Ngo8k841zv
8. U63s13uaor
9. 61-96-1
10. Nordefrin Hydrochloride
11. 1,2-benzenediol,4-[(1r,2s)-2-amino-1-hydroxypropyl]-, Hydrochloride (1:1)
12. Corbadrine Hcl
13. (r-(r*,s*))-4-(2-amino-1-hydroxypropyl)pyrocatechol Hydrochloride
14. [r-(r*,s*)]-4-(2-amino-1-hydroxypropyl)pyrocatechol Hydrochloride
15. Unii-u63s13uaor
16. (-)-nordefrin Hydrochloride
17. Cobefrin
18. Corbasil
19. 4-[(1r,2s)-2-amino-1-hydroxypropyl]benzene-1,2-diol;hydrochloride
20. Einecs 233-853-4
21. (-)-alpha-methylnoradrenaline Hydrochloride
22. Unii-ngo8k841zv
23. Schembl363800
24. Dtxsid00146134
25. Einecs 200-524-1
26. Nordefrin Hydrochloride [mi]
27. (+/-)-cobefrin Hydrochloride
28. Nordefrin Hydrochloride [who-dd]
29. Corbadrine Hydrochloride [who-dd]
30. Nordefrin Hydrochloride (r*,s*)-(+-)-
31. (+/-)-.alpha.-methylnoradrenaline Hydrochloride
32. (r*,s*)-(1)-4-(2-amino-1-hydroxypropyl)pyrocatechol Hydrochloride
33. (+/-)-ga-(1-aminoethyl)-3,4-dihydroxybenzyl Alcohol Hydrochloride
34. (-)-2-amino-1-(3,4-dihydroxyphenyl)propan-1-ol Hydrochloride
35. 1,2-benzenediol, 4-((1r,2s)-2-amino-1-hydroxypropyl)-, Hydrochloride (1:1)
36. 1,2-benzenediol, 4-((1r,2s)-2-amino-1-hydroxypropyl)-, Hydrochloride, Rel-
37. 1,2-benzenediol, 4-((1r,2s)-2-amino-1-hydroxypropyl)-, Hydrochloride (1:1), Rel-
38. Benzyl Alcohol, .alpha.-(1-aminoethyl)-3,4-dihydroxy-, Hydrochloride, Erythro-(+/-)-
| Molecular Weight | 219.66 g/mol |
|---|---|
| Molecular Formula | C9H14ClNO3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 219.0662210 g/mol |
| Monoisotopic Mass | 219.0662210 g/mol |
| Topological Polar Surface Area | 86.7 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 165 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
ABOUT THIS PAGE
A Levonordefrin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levonordefrin Hydrochloride, including repackagers and relabelers. The FDA regulates Levonordefrin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levonordefrin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Levonordefrin Hydrochloride supplier is an individual or a company that provides Levonordefrin Hydrochloride active pharmaceutical ingredient (API) or Levonordefrin Hydrochloride finished formulations upon request. The Levonordefrin Hydrochloride suppliers may include Levonordefrin Hydrochloride API manufacturers, exporters, distributors and traders.
Levonordefrin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levonordefrin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levonordefrin Hydrochloride GMP manufacturer or Levonordefrin Hydrochloride GMP API supplier for your needs.
A Levonordefrin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Levonordefrin Hydrochloride's compliance with Levonordefrin Hydrochloride specifications and serves as a tool for batch-level quality control.
Levonordefrin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Levonordefrin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levonordefrin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Levonordefrin Hydrochloride EP), Levonordefrin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levonordefrin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
